| __timestamp | Summit Therapeutics Inc. | Xenon Pharmaceuticals Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 15635076 | 11768000 |
| Thursday, January 1, 2015 | 23943601 | 15152000 |
| Friday, January 1, 2016 | 23689111 | 19828000 |
| Sunday, January 1, 2017 | 41006114 | 25573000 |
| Monday, January 1, 2018 | 51379106 | 23634000 |
| Tuesday, January 1, 2019 | 32705593 | 38845000 |
| Wednesday, January 1, 2020 | 53274000 | 50523000 |
| Friday, January 1, 2021 | 85352000 | 75463000 |
| Saturday, January 1, 2022 | 51999000 | 105767000 |
| Sunday, January 1, 2023 | 59471000 | 167512000 |
Infusing magic into the data realm
In the ever-evolving landscape of biotechnology, research and development (R&D) are the lifeblood of innovation. Over the past decade, Summit Therapeutics Inc. and Xenon Pharmaceuticals Inc. have been at the forefront of this transformative journey.
Summit Therapeutics has shown a steady commitment to R&D, with expenses growing by approximately 280% from 2014 to 2023. Notably, their R&D spending peaked in 2021, reflecting a strategic push towards groundbreaking therapies.
Xenon Pharmaceuticals, on the other hand, has demonstrated a more aggressive R&D strategy, with a staggering 1,320% increase in expenses over the same period. Their investment crescendoed in 2023, underscoring their dedication to pioneering neurological treatments.
These trends highlight the dynamic nature of biotech R&D, where strategic investments can lead to significant advancements in medical science.
Comparing Innovation Spending: Pfizer Inc. and Summit Therapeutics Inc.
Who Prioritizes Innovation? R&D Spending Compared for Alnylam Pharmaceuticals, Inc. and Xenon Pharmaceuticals Inc.
Research and Development: Comparing Key Metrics for Biogen Inc. and Summit Therapeutics Inc.
Research and Development: Comparing Key Metrics for United Therapeutics Corporation and Summit Therapeutics Inc.
Research and Development Investment: Summit Therapeutics Inc. vs Geron Corporation
Summit Therapeutics Inc. or Celldex Therapeutics, Inc.: Who Invests More in Innovation?
Comparing Innovation Spending: Summit Therapeutics Inc. and Viridian Therapeutics, Inc.
Bio-Techne Corporation vs Xenon Pharmaceuticals Inc.: Strategic Focus on R&D Spending
Research and Development Expenses Breakdown: PTC Therapeutics, Inc. vs Xenon Pharmaceuticals Inc.
Who Prioritizes Innovation? R&D Spending Compared for Perrigo Company plc and Xenon Pharmaceuticals Inc.
Research and Development Expenses Breakdown: Xenon Pharmaceuticals Inc. vs Travere Therapeutics, Inc.